Harvard Business Review May 10, 2019
Albert SiuLinda and V. DeCherrie

Since early pilot tests of the hospital-at-home model in the United States more than 20 years ago, the promise of treating patients where they live instead of hospitalizing them has tantalized health care providers.

These programs, which care for patients with acute illnesses such as pneumonia, cellulitis, and exacerbations of congestive heart failure and chronic obstructive pulmonary disease (COPD), are among the most studied innovations in health care. That research has shown varying but clearly positive impacts on mortality, clinical outcomes, readmission rates, and cost. A 2012 meta-analysis of 61 randomized, controlled trials, for instance, found that the hospital-at-home patients had a 19% lower six-month mortality rate compared to hospitalized patients. Another review found the rate reduced...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Home, Patient / Consumer, Physician, Provider
FDA launches initiative to advance home healthcare models, devices
Novant Health launches 'hospital at home' with $2.7M donation
FDA initiative puts AR/VR at heart of home health drive
Understanding the Value of the Home as a Healthcare Site
BrightStar Care Dives Further Into Hospital-At-Home Care, Expands Partnership With Medically Home

Share This Article